These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1454750)

  • 1. Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.
    Horsmans Y; Desager JP; Harvengt C
    Pharmacol Toxicol; 1992 Oct; 71(4):258-61. PubMed ID: 1454750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations.
    Kovacs SJ; Martin DE; Everitt DE; Patterson SD; Jorkasky DK
    Clin Pharmacol Ther; 1998 Jun; 63(6):617-22. PubMed ID: 9663175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in urinary excretion of 6beta-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction.
    Totsuka S; Watanabe T; Koyanagi F; Tanaka K; Yasuda M; Manabe S
    Arch Toxicol; 1999; 73(4-5):203-7. PubMed ID: 10463384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol.
    Koup JR; Anderson GD; Loi CM
    J Clin Pharmacol; 1998 Sep; 38(9):815-8. PubMed ID: 9753209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of grapefruit juice on urinary 6 beta-hydroxycortisol/cortisol excretion.
    Seidegård J; Dahlström K; Kullberg A
    Clin Exp Pharmacol Physiol; 1998 May; 25(5):379-81. PubMed ID: 9612666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of amiodarone on urinary excretion of 6beta-hydroxycortisol in humans.
    Micuda S; Hodac M; Sispera L; Parízek P; Pleskot M; Zimova G; Cerman J; Martínková J; Pidrman V
    Physiol Res; 2001; 50(2):191-6. PubMed ID: 11522047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
    Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
    Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis.
    Dilger K; Denk A; Heeg MH; Beuers U
    Hepatology; 2005 Mar; 41(3):595-602. PubMed ID: 15726657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midazolam and cortisol metabolism before and after CYP3A induction in humans.
    Eeckhoudt SL; Desager JP; Robert AR; Leclercq I; Verbeeck RK; Horsmans Y
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):293-9. PubMed ID: 11471773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin.
    Stärkel P; Sempoux C; Van Den Berge V; Stevens M; De Saeger C; Desager JP; Horsmans Y
    Life Sci; 1999; 64(8):643-53. PubMed ID: 10069527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.
    Ohno M; Yamaguchi I; Ito T; Saiki K; Yamamoto I; Azuma J
    Eur J Clin Pharmacol; 2000; 55(11-12):861-5. PubMed ID: 10805065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE; Peng B; Hubert M; Krebs-Brown A; Capdeville R; Keller U; Seiberling M
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A wide interindividual variability of urinary 6beta-hydroxycortisol to free cortisol in 487 healthy Japanese subjects in near basal condition.
    Inagaki K; Inagaki M; Kataoka T; Sekido I; Gill MA; Nishida M
    Ther Drug Monit; 2002 Dec; 24(6):722-7. PubMed ID: 12451288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.
    Ged C; Rouillon JM; Pichard L; Combalbert J; Bressot N; Bories P; Michel H; Beaune P; Maurel P
    Br J Clin Pharmacol; 1989 Oct; 28(4):373-87. PubMed ID: 2590599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.
    Galteau MM; Shamsa F
    Eur J Clin Pharmacol; 2003 Dec; 59(10):713-33. PubMed ID: 14605790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEET (N,N-diethyl-m-toluamide) alone and in combination with permethrin increased urinary excretion of 6beta-hydroxycortisol in rats, a marker of hepatic CYP3A induction.
    Abu-Qare AW; Abou-Donia MB
    J Toxicol Environ Health A; 2001 Nov; 64(5):373-84. PubMed ID: 11700004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP3A metabolizer status on the pharmacokinetics and pharmacodynamics of amiodarone.
    Micuda S; Hodac M; Parízek P; Pleskot M; Sispera L; Cerman J; Maláková J; Martínková J; Pidrman V
    Acta Medica (Hradec Kralove); 2000; 43(3):95-101. PubMed ID: 11089277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men.
    Kinirons MT; O'Shea D; Downing TE; Fitzwilliam AT; Joellenbeck L; Groopman JD; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1993 Dec; 54(6):621-9. PubMed ID: 8275617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.